Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Epizyme Company Profile (NASDAQ:EPZM)

Consensus Ratings for Epizyme (NASDAQ:EPZM) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $36.78 (10.90% upside)

Analysts' Ratings History for Epizyme (NASDAQ:EPZM)
Show:
DateFirmActionRatingPrice TargetDetailsShare
7/15/2014WainwrightInitiated CoverageBuy$40.00ViewTweet This Rating  Share This Rating on StockTwits
7/15/2014HC WainwrightInitiated CoverageBuy$40.00ViewTweet This Rating  Share This Rating on StockTwits
7/9/2014ZacksUpgradeNeutral -> Outperform$35.10ViewTweet This Rating  Share This Rating on StockTwits
11/15/2013Citigroup Inc.Reiterated RatingBuy$42.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
6/26/2013WedbushInitiated CoverageOutperform$37.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2013JMP SecuritiesInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
6/25/2013Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
6/25/2013Leerink SwannInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
6/25/2013Citigroup Inc.Initiated CoverageBuy$32.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2012 forward)